Global Canine Arthritis Treatment Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 107705
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Canine Arthritis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Canine Arthritis Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Veterinary Hospitals and Clinics accounting for % of the Canine Arthritis Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Non-Steroidal Anti-Inflammatory Drugs segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Canine Arthritis Treatment include Elanco (Eli Lilly and Company), Boehringer Ingelheim, Zoetis Inc, Vetoquinol S.A., and Bayer AG, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Canine Arthritis Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Non-Steroidal Anti-Inflammatory Drugs

Opioids

Market segment by Application, can be divided into

Veterinary Hospitals and Clinics

Drug Stores

E-commerce

Market segment by players, this report covers

Elanco (Eli Lilly and Company)

Boehringer Ingelheim

Zoetis Inc

Vetoquinol S.A.

Bayer AG

Aratana Therapeutics Inc

Norbrook Laboratories Limited

VetStem Biopharma

Dechra Pharmaceuticals Plc

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Canine Arthritis Treatment product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Canine Arthritis Treatment, with revenue, gross margin and global market share of Canine Arthritis Treatment from 2019 to 2022.

Chapter 3, the Canine Arthritis Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Canine Arthritis Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Canine Arthritis Treatment research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Canine Arthritis Treatment

1.2 Classification of Canine Arthritis Treatment by Type

1.2.1 Overview: Global Canine Arthritis Treatment Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Canine Arthritis Treatment Revenue Market Share by Type in 2021

1.2.3 Non-Steroidal Anti-Inflammatory Drugs

1.2.4 Opioids

1.3 Global Canine Arthritis Treatment Market by Application

1.3.1 Overview: Global Canine Arthritis Treatment Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Veterinary Hospitals and Clinics

1.3.3 Drug Stores

1.3.4 E-commerce

1.4 Global Canine Arthritis Treatment Market Size & Forecast

1.5 Global Canine Arthritis Treatment Market Size and Forecast by Region

1.5.1 Global Canine Arthritis Treatment Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Canine Arthritis Treatment Market Size by Region, (2017-2022)

1.5.3 North America Canine Arthritis Treatment Market Size and Prospect (2017-2028)

1.5.4 Europe Canine Arthritis Treatment Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Canine Arthritis Treatment Market Size and Prospect (2017-2028)

1.5.6 South America Canine Arthritis Treatment Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Canine Arthritis Treatment Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Canine Arthritis Treatment Market Drivers

1.6.2 Canine Arthritis Treatment Market Restraints

1.6.3 Canine Arthritis Treatment Trends Analysis

2 Company Profiles

2.1 Elanco (Eli Lilly and Company)

2.1.1 Elanco (Eli Lilly and Company) Details

2.1.2 Elanco (Eli Lilly and Company) Major Business

2.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Product and Solutions

2.1.4 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Elanco (Eli Lilly and Company) Recent Developments and Future Plans

2.2 Boehringer Ingelheim

2.2.1 Boehringer Ingelheim Details

2.2.2 Boehringer Ingelheim Major Business

2.2.3 Boehringer Ingelheim Canine Arthritis Treatment Product and Solutions

2.2.4 Boehringer Ingelheim Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Boehringer Ingelheim Recent Developments and Future Plans

2.3 Zoetis Inc

2.3.1 Zoetis Inc Details

2.3.2 Zoetis Inc Major Business

2.3.3 Zoetis Inc Canine Arthritis Treatment Product and Solutions

2.3.4 Zoetis Inc Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Zoetis Inc Recent Developments and Future Plans

2.4 Vetoquinol S.A.

2.4.1 Vetoquinol S.A. Details

2.4.2 Vetoquinol S.A. Major Business

2.4.3 Vetoquinol S.A. Canine Arthritis Treatment Product and Solutions

2.4.4 Vetoquinol S.A. Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Vetoquinol S.A. Recent Developments and Future Plans

2.5 Bayer AG

2.5.1 Bayer AG Details

2.5.2 Bayer AG Major Business

2.5.3 Bayer AG Canine Arthritis Treatment Product and Solutions

2.5.4 Bayer AG Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Bayer AG Recent Developments and Future Plans

2.6 Aratana Therapeutics Inc

2.6.1 Aratana Therapeutics Inc Details

2.6.2 Aratana Therapeutics Inc Major Business

2.6.3 Aratana Therapeutics Inc Canine Arthritis Treatment Product and Solutions

2.6.4 Aratana Therapeutics Inc Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Aratana Therapeutics Inc Recent Developments and Future Plans

2.7 Norbrook Laboratories Limited

2.7.1 Norbrook Laboratories Limited Details

2.7.2 Norbrook Laboratories Limited Major Business

2.7.3 Norbrook Laboratories Limited Canine Arthritis Treatment Product and Solutions

2.7.4 Norbrook Laboratories Limited Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Norbrook Laboratories Limited Recent Developments and Future Plans

2.8 VetStem Biopharma

2.8.1 VetStem Biopharma Details

2.8.2 VetStem Biopharma Major Business

2.8.3 VetStem Biopharma Canine Arthritis Treatment Product and Solutions

2.8.4 VetStem Biopharma Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 VetStem Biopharma Recent Developments and Future Plans

2.9 Dechra Pharmaceuticals Plc

2.9.1 Dechra Pharmaceuticals Plc Details

2.9.2 Dechra Pharmaceuticals Plc Major Business

2.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Product and Solutions

2.9.4 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Dechra Pharmaceuticals Plc Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Canine Arthritis Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Canine Arthritis Treatment Players Market Share in 2021

3.2.2 Top 10 Canine Arthritis Treatment Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Canine Arthritis Treatment Players Head Office, Products and Services Provided

3.4 Canine Arthritis Treatment Mergers & Acquisitions

3.5 Canine Arthritis Treatment New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Canine Arthritis Treatment Revenue and Market Share by Type (2017-2022)

4.2 Global Canine Arthritis Treatment Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Canine Arthritis Treatment Revenue Market Share by Application (2017-2022)

5.2 Global Canine Arthritis Treatment Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Canine Arthritis Treatment Revenue by Type (2017-2028)

6.2 North America Canine Arthritis Treatment Revenue by Application (2017-2028)

6.3 North America Canine Arthritis Treatment Market Size by Country

6.3.1 North America Canine Arthritis Treatment Revenue by Country (2017-2028)

6.3.2 United States Canine Arthritis Treatment Market Size and Forecast (2017-2028)

6.3.3 Canada Canine Arthritis Treatment Market Size and Forecast (2017-2028)

6.3.4 Mexico Canine Arthritis Treatment Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Canine Arthritis Treatment Revenue by Type (2017-2028)

7.2 Europe Canine Arthritis Treatment Revenue by Application (2017-2028)

7.3 Europe Canine Arthritis Treatment Market Size by Country

7.3.1 Europe Canine Arthritis Treatment Revenue by Country (2017-2028)

7.3.2 Germany Canine Arthritis Treatment Market Size and Forecast (2017-2028)

7.3.3 France Canine Arthritis Treatment Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Canine Arthritis Treatment Market Size and Forecast (2017-2028)

7.3.5 Russia Canine Arthritis Treatment Market Size and Forecast (2017-2028)

7.3.6 Italy Canine Arthritis Treatment Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Canine Arthritis Treatment Revenue by Type (2017-2028)

8.2 Asia-Pacific Canine Arthritis Treatment Revenue by Application (2017-2028)

8.3 Asia-Pacific Canine Arthritis Treatment Market Size by Region

8.3.1 Asia-Pacific Canine Arthritis Treatment Revenue by Region (2017-2028)

8.3.2 China Canine Arthritis Treatment Market Size and Forecast (2017-2028)

8.3.3 Japan Canine Arthritis Treatment Market Size and Forecast (2017-2028)

8.3.4 South Korea Canine Arthritis Treatment Market Size and Forecast (2017-2028)

8.3.5 India Canine Arthritis Treatment Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Canine Arthritis Treatment Market Size and Forecast (2017-2028)

8.3.7 Australia Canine Arthritis Treatment Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Canine Arthritis Treatment Revenue by Type (2017-2028)

9.2 South America Canine Arthritis Treatment Revenue by Application (2017-2028)

9.3 South America Canine Arthritis Treatment Market Size by Country

9.3.1 South America Canine Arthritis Treatment Revenue by Country (2017-2028)

9.3.2 Brazil Canine Arthritis Treatment Market Size and Forecast (2017-2028)

9.3.3 Argentina Canine Arthritis Treatment Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Canine Arthritis Treatment Revenue by Type (2017-2028)

10.2 Middle East & Africa Canine Arthritis Treatment Revenue by Application (2017-2028)

10.3 Middle East & Africa Canine Arthritis Treatment Market Size by Country

10.3.1 Middle East & Africa Canine Arthritis Treatment Revenue by Country (2017-2028)

10.3.2 Turkey Canine Arthritis Treatment Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Canine Arthritis Treatment Market Size and Forecast (2017-2028)

10.3.4 UAE Canine Arthritis Treatment Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Canine Arthritis Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Canine Arthritis Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Canine Arthritis Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Canine Arthritis Treatment Revenue (USD Million) by Region (2017-2022)

Table 5. Global Canine Arthritis Treatment Revenue Market Share by Region (2023-2028)

Table 6. Elanco (Eli Lilly and Company) Corporate Information, Head Office, and Major Competitors

Table 7. Elanco (Eli Lilly and Company) Major Business

Table 8. Elanco (Eli Lilly and Company) Canine Arthritis Treatment Product and Solutions

Table 9. Elanco (Eli Lilly and Company) Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors

Table 11. Boehringer Ingelheim Major Business

Table 12. Boehringer Ingelheim Canine Arthritis Treatment Product and Solutions

Table 13. Boehringer Ingelheim Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Zoetis Inc Corporate Information, Head Office, and Major Competitors

Table 15. Zoetis Inc Major Business

Table 16. Zoetis Inc Canine Arthritis Treatment Product and Solutions

Table 17. Zoetis Inc Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Vetoquinol S.A. Corporate Information, Head Office, and Major Competitors

Table 19. Vetoquinol S.A. Major Business

Table 20. Vetoquinol S.A. Canine Arthritis Treatment Product and Solutions

Table 21. Vetoquinol S.A. Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Bayer AG Corporate Information, Head Office, and Major Competitors

Table 23. Bayer AG Major Business

Table 24. Bayer AG Canine Arthritis Treatment Product and Solutions

Table 25. Bayer AG Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Aratana Therapeutics Inc Corporate Information, Head Office, and Major Competitors

Table 27. Aratana Therapeutics Inc Major Business

Table 28. Aratana Therapeutics Inc Canine Arthritis Treatment Product and Solutions

Table 29. Aratana Therapeutics Inc Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Norbrook Laboratories Limited Corporate Information, Head Office, and Major Competitors

Table 31. Norbrook Laboratories Limited Major Business

Table 32. Norbrook Laboratories Limited Canine Arthritis Treatment Product and Solutions

Table 33. Norbrook Laboratories Limited Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. VetStem Biopharma Corporate Information, Head Office, and Major Competitors

Table 35. VetStem Biopharma Major Business

Table 36. VetStem Biopharma Canine Arthritis Treatment Product and Solutions

Table 37. VetStem Biopharma Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Dechra Pharmaceuticals Plc Corporate Information, Head Office, and Major Competitors

Table 39. Dechra Pharmaceuticals Plc Major Business

Table 40. Dechra Pharmaceuticals Plc Canine Arthritis Treatment Product and Solutions

Table 41. Dechra Pharmaceuticals Plc Canine Arthritis Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Global Canine Arthritis Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 43. Global Canine Arthritis Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 44. Breakdown of Canine Arthritis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 45. Canine Arthritis Treatment Players Head Office, Products and Services Provided

Table 46. Canine Arthritis Treatment Mergers & Acquisitions in the Past Five Years

Table 47. Canine Arthritis Treatment New Entrants and Expansion Plans

Table 48. Global Canine Arthritis Treatment Revenue (USD Million) by Type (2017-2022)

Table 49. Global Canine Arthritis Treatment Revenue Share by Type (2017-2022)

Table 50. Global Canine Arthritis Treatment Revenue Forecast by Type (2023-2028)

Table 51. Global Canine Arthritis Treatment Revenue by Application (2017-2022)

Table 52. Global Canine Arthritis Treatment Revenue Forecast by Application (2023-2028)

Table 53. North America Canine Arthritis Treatment Revenue by Type (2017-2022) & (USD Million)

Table 54. North America Canine Arthritis Treatment Revenue by Type (2023-2028) & (USD Million)

Table 55. North America Canine Arthritis Treatment Revenue by Application (2017-2022) & (USD Million)

Table 56. North America Canine Arthritis Treatment Revenue by Application (2023-2028) & (USD Million)

Table 57. North America Canine Arthritis Treatment Revenue by Country (2017-2022) & (USD Million)

Table 58. North America Canine Arthritis Treatment Revenue by Country (2023-2028) & (USD Million)

Table 59. Europe Canine Arthritis Treatment Revenue by Type (2017-2022) & (USD Million)

Table 60. Europe Canine Arthritis Treatment Revenue by Type (2023-2028) & (USD Million)

Table 61. Europe Canine Arthritis Treatment Revenue by Application (2017-2022) & (USD Million)

Table 62. Europe Canine Arthritis Treatment Revenue by Application (2023-2028) & (USD Million)

Table 63. Europe Canine Arthritis Treatment Revenue by Country (2017-2022) & (USD Million)

Table 64. Europe Canine Arthritis Treatment Revenue by Country (2023-2028) & (USD Million)

Table 65. Asia-Pacific Canine Arthritis Treatment Revenue by Type (2017-2022) & (USD Million)

Table 66. Asia-Pacific Canine Arthritis Treatment Revenue by Type (2023-2028) & (USD Million)

Table 67. Asia-Pacific Canine Arthritis Treatment Revenue by Application (2017-2022) & (USD Million)

Table 68. Asia-Pacific Canine Arthritis Treatment Revenue by Application (2023-2028) & (USD Million)

Table 69. Asia-Pacific Canine Arthritis Treatment Revenue by Region (2017-2022) & (USD Million)

Table 70. Asia-Pacific Canine Arthritis Treatment Revenue by Region (2023-2028) & (USD Million)

Table 71. South America Canine Arthritis Treatment Revenue by Type (2017-2022) & (USD Million)

Table 72. South America Canine Arthritis Treatment Revenue by Type (2023-2028) & (USD Million)

Table 73. South America Canine Arthritis Treatment Revenue by Application (2017-2022) & (USD Million)

Table 74. South America Canine Arthritis Treatment Revenue by Application (2023-2028) & (USD Million)

Table 75. South America Canine Arthritis Treatment Revenue by Country (2017-2022) & (USD Million)

Table 76. South America Canine Arthritis Treatment Revenue by Country (2023-2028) & (USD Million)

Table 77. Middle East & Africa Canine Arthritis Treatment Revenue by Type (2017-2022) & (USD Million)

Table 78. Middle East & Africa Canine Arthritis Treatment Revenue by Type (2023-2028) & (USD Million)

Table 79. Middle East & Africa Canine Arthritis Treatment Revenue by Application (2017-2022) & (USD Million)

Table 80. Middle East & Africa Canine Arthritis Treatment Revenue by Application (2023-2028) & (USD Million)

Table 81. Middle East & Africa Canine Arthritis Treatment Revenue by Country (2017-2022) & (USD Million)

Table 82. Middle East & Africa Canine Arthritis Treatment Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Canine Arthritis Treatment Picture

Figure 2. Global Canine Arthritis Treatment Revenue Market Share by Type in 2021

Figure 3. Non-Steroidal Anti-Inflammatory Drugs

Figure 4. Opioids

Figure 5. Canine Arthritis Treatment Revenue Market Share by Application in 2021

Figure 6. Veterinary Hospitals and Clinics Picture

Figure 7. Drug Stores Picture

Figure 8. E-commerce Picture

Figure 9. Global Canine Arthritis Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Canine Arthritis Treatment Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Canine Arthritis Treatment Revenue Market Share by Region (2017-2028)

Figure 12. Global Canine Arthritis Treatment Revenue Market Share by Region in 2021

Figure 13. North America Canine Arthritis Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Canine Arthritis Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Canine Arthritis Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Canine Arthritis Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Canine Arthritis Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Canine Arthritis Treatment Market Drivers

Figure 19. Canine Arthritis Treatment Market Restraints

Figure 20. Canine Arthritis Treatment Market Trends

Figure 21. Elanco (Eli Lilly and Company) Recent Developments and Future Plans

Figure 22. Boehringer Ingelheim Recent Developments and Future Plans

Figure 23. Zoetis Inc Recent Developments and Future Plans

Figure 24. Vetoquinol S.A. Recent Developments and Future Plans

Figure 25. Bayer AG Recent Developments and Future Plans

Figure 26. Aratana Therapeutics Inc Recent Developments and Future Plans

Figure 27. Norbrook Laboratories Limited Recent Developments and Future Plans

Figure 28. VetStem Biopharma Recent Developments and Future Plans

Figure 29. Dechra Pharmaceuticals Plc Recent Developments and Future Plans

Figure 30. Global Canine Arthritis Treatment Revenue Share by Players in 2021

Figure 31. Canine Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 32. Global Top 3 Players Canine Arthritis Treatment Revenue Market Share in 2021

Figure 33. Global Top 10 Players Canine Arthritis Treatment Revenue Market Share in 2021

Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 35. Global Canine Arthritis Treatment Revenue Share by Type in 2021

Figure 36. Global Canine Arthritis Treatment Market Share Forecast by Type (2023-2028)

Figure 37. Global Canine Arthritis Treatment Revenue Share by Application in 2021

Figure 38. Global Canine Arthritis Treatment Market Share Forecast by Application (2023-2028)

Figure 39. North America Canine Arthritis Treatment Sales Market Share by Type (2017-2028)

Figure 40. North America Canine Arthritis Treatment Sales Market Share by Application (2017-2028)

Figure 41. North America Canine Arthritis Treatment Revenue Market Share by Country (2017-2028)

Figure 42. United States Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Canada Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Mexico Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Europe Canine Arthritis Treatment Sales Market Share by Type (2017-2028)

Figure 46. Europe Canine Arthritis Treatment Sales Market Share by Application (2017-2028)

Figure 47. Europe Canine Arthritis Treatment Revenue Market Share by Country (2017-2028)

Figure 48. Germany Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. France Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. United Kingdom Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Russia Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Italy Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Asia-Pacific Canine Arthritis Treatment Sales Market Share by Type (2017-2028)

Figure 54. Asia-Pacific Canine Arthritis Treatment Sales Market Share by Application (2017-2028)

Figure 55. Asia-Pacific Canine Arthritis Treatment Revenue Market Share by Region (2017-2028)

Figure 56. China Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Japan Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. South Korea Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. India Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Southeast Asia Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Australia Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South America Canine Arthritis Treatment Sales Market Share by Type (2017-2028)

Figure 63. South America Canine Arthritis Treatment Sales Market Share by Application (2017-2028)

Figure 64. South America Canine Arthritis Treatment Revenue Market Share by Country (2017-2028)

Figure 65. Brazil Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Argentina Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Middle East and Africa Canine Arthritis Treatment Sales Market Share by Type (2017-2028)

Figure 68. Middle East and Africa Canine Arthritis Treatment Sales Market Share by Application (2017-2028)

Figure 69. Middle East and Africa Canine Arthritis Treatment Revenue Market Share by Country (2017-2028)

Figure 70. Turkey Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Saudi Arabia Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. UAE Canine Arthritis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Methodology

Figure 74. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz